Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer

Background Identifying the target of natural killer (NK) cells in colorectal cancer (CRC) is critical for optimising the clinical use of NK cell-mediated immunotherapy. Mismatch repair deficiency (dMMR) is associated with high immune cell infiltration and MHC Class I defects. Whether dMMR CRC respon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of cancer 2024-07, Vol.131 (2), p.334-346
Hauptverfasser: Yang, Lin, Yi, Jiahong, He, Wenzhuo, Kong, Pengfei, Xie, Qiankun, Jin, Yanan, Xiong, Zhenchong, Xia, Liangping
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 346
container_issue 2
container_start_page 334
container_title British journal of cancer
container_volume 131
creator Yang, Lin
Yi, Jiahong
He, Wenzhuo
Kong, Pengfei
Xie, Qiankun
Jin, Yanan
Xiong, Zhenchong
Xia, Liangping
description Background Identifying the target of natural killer (NK) cells in colorectal cancer (CRC) is critical for optimising the clinical use of NK cell-mediated immunotherapy. Mismatch repair deficiency (dMMR) is associated with high immune cell infiltration and MHC Class I defects. Whether dMMR CRC responses to NK cell therapy remains unclear. Methods MLH1, DR4, and DR5 knockout cell lines were established using CRISPR-Cas9 system. NK92-MI or NK cell isolated from BABL/C mice were used as effector cells against tumour cells. Inflammatory cytokines secretion by CRC cells was assessed via cytokine analysis. NK-cell-deficient/proficient animal models were used to validate the NK cell sensitivity. Results We observed that dMMR CRC cells were more sensitive to NK cell-mediated cytotoxicity than were mismatch-repair-proficient (pMMR) CRC cells. In dMMR CRC, Death receptor (DR)4/5 was upregulated and mediated sensitivity to NK cell-mediated cytotoxicity. DR4/5-mediated secretion of interleukin -12 sustained NK cell viability in dMMR CRC. NK cell depletion induced dMMR CRC tumour growth, and NK cell transfer inhibited lung metastasis of dMMR CRC with DR4/5 expression in vivo. TP53 upregulated DR4/DR5 expression in dMMR CRC. Conclusions dMMR associated with increased sensitivity to NK cell-mediated cytotoxicity in CRC. DR4/DR5 sensitise dMMR CRC to NK cell-mediated cytotoxicity.
doi_str_mv 10.1038/s41416-024-02673-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_pubmed_primary_38796599</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3060747618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c171z-b242c628ac12a069509c53c5d250482eec124dbf39738b2af7a39cb6866666843</originalsourceid><addsrcrecordid>eNp9kU2PFCEQhonRuOPqH_BgSLx4aZevBvpo1s9kEy96JjRdrazdzQi0ceYn-KutdkZNPEhSIVBPvVXwEvKYs-ecSXtVFFdcN0woDG1kc7xDdryVouFWmLtkxxgzDesEuyAPSrnFY8esuU8upDWdbrtuR368BF8_0wwB9jXlQtVVS2cYoq9A6zqnNdMCS4k1fov1QGuii69r9hP9EqcJMg0wTc25YqDhUFNN32PY4LjQOZbZ17B12PuY6QAj5mCpNKQpYduKSsEvAfJDcm_0U4FH5_2SfHz96sP12-bm_Zt31y9umsANPza9UCJoYX3gwjPdtawLrQztIFqmrADAezX0o-yMtL3wo_GyC722eltWyUvy7KS7z-nrCqU6HHJ7hV8grcVJpplRRnOL6NN_0Fv8kAWnQ8pKDK0FUuJEhZxKyTC6fY6zzwfHmduccienHDrlfjnljlj05Cy99vh7f0p-W4OAPAEFU8snyH97_0f2JyDToN8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3083308662</pqid></control><display><type>article</type><title>Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Yang, Lin ; Yi, Jiahong ; He, Wenzhuo ; Kong, Pengfei ; Xie, Qiankun ; Jin, Yanan ; Xiong, Zhenchong ; Xia, Liangping</creator><creatorcontrib>Yang, Lin ; Yi, Jiahong ; He, Wenzhuo ; Kong, Pengfei ; Xie, Qiankun ; Jin, Yanan ; Xiong, Zhenchong ; Xia, Liangping</creatorcontrib><description>Background Identifying the target of natural killer (NK) cells in colorectal cancer (CRC) is critical for optimising the clinical use of NK cell-mediated immunotherapy. Mismatch repair deficiency (dMMR) is associated with high immune cell infiltration and MHC Class I defects. Whether dMMR CRC responses to NK cell therapy remains unclear. Methods MLH1, DR4, and DR5 knockout cell lines were established using CRISPR-Cas9 system. NK92-MI or NK cell isolated from BABL/C mice were used as effector cells against tumour cells. Inflammatory cytokines secretion by CRC cells was assessed via cytokine analysis. NK-cell-deficient/proficient animal models were used to validate the NK cell sensitivity. Results We observed that dMMR CRC cells were more sensitive to NK cell-mediated cytotoxicity than were mismatch-repair-proficient (pMMR) CRC cells. In dMMR CRC, Death receptor (DR)4/5 was upregulated and mediated sensitivity to NK cell-mediated cytotoxicity. DR4/5-mediated secretion of interleukin -12 sustained NK cell viability in dMMR CRC. NK cell depletion induced dMMR CRC tumour growth, and NK cell transfer inhibited lung metastasis of dMMR CRC with DR4/5 expression in vivo. TP53 upregulated DR4/DR5 expression in dMMR CRC. Conclusions dMMR associated with increased sensitivity to NK cell-mediated cytotoxicity in CRC. DR4/DR5 sensitise dMMR CRC to NK cell-mediated cytotoxicity.</description><identifier>ISSN: 0007-0920</identifier><identifier>ISSN: 1532-1827</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/s41416-024-02673-z</identifier><identifier>PMID: 38796599</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/499 ; 692/53/2422 ; Animal models ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Brain Neoplasms ; Cancer Research ; Cell culture ; Cell death ; Cell Line, Tumor ; Cell therapy ; Cell viability ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms - genetics ; Colorectal Neoplasms - immunology ; Colorectal Neoplasms - pathology ; CRISPR ; Cytotoxicity ; Cytotoxicity, Immunologic ; Death receptors ; DNA Mismatch Repair ; Drug Resistance ; Effector cells ; Epidemiology ; Humans ; Immunotherapy ; Killer Cells, Natural - immunology ; Killer Cells, Natural - metabolism ; Major histocompatibility complex ; Metastases ; Mice ; Mice, Inbred BALB C ; Mismatch repair ; MLH1 protein ; Molecular Medicine ; MutL Protein Homolog 1 - deficiency ; MutL Protein Homolog 1 - genetics ; MutL Protein Homolog 1 - metabolism ; Natural killer cells ; Neoplastic Syndromes, Hereditary - genetics ; Neoplastic Syndromes, Hereditary - immunology ; Neoplastic Syndromes, Hereditary - pathology ; Oncology ; Receptors, TNF-Related Apoptosis-Inducing Ligand - genetics ; Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism ; Tumors</subject><ispartof>British journal of cancer, 2024-07, Vol.131 (2), p.334-346</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2024. corrected publication 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer Nature Limited.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c171z-b242c628ac12a069509c53c5d250482eec124dbf39738b2af7a39cb6866666843</cites><orcidid>0000-0003-4544-8071 ; 0000-0001-7532-4913 ; 0000-0002-1129-5663</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41416-024-02673-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41416-024-02673-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38796599$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Lin</creatorcontrib><creatorcontrib>Yi, Jiahong</creatorcontrib><creatorcontrib>He, Wenzhuo</creatorcontrib><creatorcontrib>Kong, Pengfei</creatorcontrib><creatorcontrib>Xie, Qiankun</creatorcontrib><creatorcontrib>Jin, Yanan</creatorcontrib><creatorcontrib>Xiong, Zhenchong</creatorcontrib><creatorcontrib>Xia, Liangping</creatorcontrib><title>Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Background Identifying the target of natural killer (NK) cells in colorectal cancer (CRC) is critical for optimising the clinical use of NK cell-mediated immunotherapy. Mismatch repair deficiency (dMMR) is associated with high immune cell infiltration and MHC Class I defects. Whether dMMR CRC responses to NK cell therapy remains unclear. Methods MLH1, DR4, and DR5 knockout cell lines were established using CRISPR-Cas9 system. NK92-MI or NK cell isolated from BABL/C mice were used as effector cells against tumour cells. Inflammatory cytokines secretion by CRC cells was assessed via cytokine analysis. NK-cell-deficient/proficient animal models were used to validate the NK cell sensitivity. Results We observed that dMMR CRC cells were more sensitive to NK cell-mediated cytotoxicity than were mismatch-repair-proficient (pMMR) CRC cells. In dMMR CRC, Death receptor (DR)4/5 was upregulated and mediated sensitivity to NK cell-mediated cytotoxicity. DR4/5-mediated secretion of interleukin -12 sustained NK cell viability in dMMR CRC. NK cell depletion induced dMMR CRC tumour growth, and NK cell transfer inhibited lung metastasis of dMMR CRC with DR4/5 expression in vivo. TP53 upregulated DR4/DR5 expression in dMMR CRC. Conclusions dMMR associated with increased sensitivity to NK cell-mediated cytotoxicity in CRC. DR4/DR5 sensitise dMMR CRC to NK cell-mediated cytotoxicity.</description><subject>692/499</subject><subject>692/53/2422</subject><subject>Animal models</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain Neoplasms</subject><subject>Cancer Research</subject><subject>Cell culture</subject><subject>Cell death</subject><subject>Cell Line, Tumor</subject><subject>Cell therapy</subject><subject>Cell viability</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Colorectal Neoplasms - immunology</subject><subject>Colorectal Neoplasms - pathology</subject><subject>CRISPR</subject><subject>Cytotoxicity</subject><subject>Cytotoxicity, Immunologic</subject><subject>Death receptors</subject><subject>DNA Mismatch Repair</subject><subject>Drug Resistance</subject><subject>Effector cells</subject><subject>Epidemiology</subject><subject>Humans</subject><subject>Immunotherapy</subject><subject>Killer Cells, Natural - immunology</subject><subject>Killer Cells, Natural - metabolism</subject><subject>Major histocompatibility complex</subject><subject>Metastases</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mismatch repair</subject><subject>MLH1 protein</subject><subject>Molecular Medicine</subject><subject>MutL Protein Homolog 1 - deficiency</subject><subject>MutL Protein Homolog 1 - genetics</subject><subject>MutL Protein Homolog 1 - metabolism</subject><subject>Natural killer cells</subject><subject>Neoplastic Syndromes, Hereditary - genetics</subject><subject>Neoplastic Syndromes, Hereditary - immunology</subject><subject>Neoplastic Syndromes, Hereditary - pathology</subject><subject>Oncology</subject><subject>Receptors, TNF-Related Apoptosis-Inducing Ligand - genetics</subject><subject>Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2PFCEQhonRuOPqH_BgSLx4aZevBvpo1s9kEy96JjRdrazdzQi0ceYn-KutdkZNPEhSIVBPvVXwEvKYs-ecSXtVFFdcN0woDG1kc7xDdryVouFWmLtkxxgzDesEuyAPSrnFY8esuU8upDWdbrtuR368BF8_0wwB9jXlQtVVS2cYoq9A6zqnNdMCS4k1fov1QGuii69r9hP9EqcJMg0wTc25YqDhUFNN32PY4LjQOZbZ17B12PuY6QAj5mCpNKQpYduKSsEvAfJDcm_0U4FH5_2SfHz96sP12-bm_Zt31y9umsANPza9UCJoYX3gwjPdtawLrQztIFqmrADAezX0o-yMtL3wo_GyC722eltWyUvy7KS7z-nrCqU6HHJ7hV8grcVJpplRRnOL6NN_0Fv8kAWnQ8pKDK0FUuJEhZxKyTC6fY6zzwfHmduccienHDrlfjnljlj05Cy99vh7f0p-W4OAPAEFU8snyH97_0f2JyDToN8</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Yang, Lin</creator><creator>Yi, Jiahong</creator><creator>He, Wenzhuo</creator><creator>Kong, Pengfei</creator><creator>Xie, Qiankun</creator><creator>Jin, Yanan</creator><creator>Xiong, Zhenchong</creator><creator>Xia, Liangping</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4544-8071</orcidid><orcidid>https://orcid.org/0000-0001-7532-4913</orcidid><orcidid>https://orcid.org/0000-0002-1129-5663</orcidid></search><sort><creationdate>202407</creationdate><title>Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer</title><author>Yang, Lin ; Yi, Jiahong ; He, Wenzhuo ; Kong, Pengfei ; Xie, Qiankun ; Jin, Yanan ; Xiong, Zhenchong ; Xia, Liangping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c171z-b242c628ac12a069509c53c5d250482eec124dbf39738b2af7a39cb6866666843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>692/499</topic><topic>692/53/2422</topic><topic>Animal models</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain Neoplasms</topic><topic>Cancer Research</topic><topic>Cell culture</topic><topic>Cell death</topic><topic>Cell Line, Tumor</topic><topic>Cell therapy</topic><topic>Cell viability</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Colorectal Neoplasms - immunology</topic><topic>Colorectal Neoplasms - pathology</topic><topic>CRISPR</topic><topic>Cytotoxicity</topic><topic>Cytotoxicity, Immunologic</topic><topic>Death receptors</topic><topic>DNA Mismatch Repair</topic><topic>Drug Resistance</topic><topic>Effector cells</topic><topic>Epidemiology</topic><topic>Humans</topic><topic>Immunotherapy</topic><topic>Killer Cells, Natural - immunology</topic><topic>Killer Cells, Natural - metabolism</topic><topic>Major histocompatibility complex</topic><topic>Metastases</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mismatch repair</topic><topic>MLH1 protein</topic><topic>Molecular Medicine</topic><topic>MutL Protein Homolog 1 - deficiency</topic><topic>MutL Protein Homolog 1 - genetics</topic><topic>MutL Protein Homolog 1 - metabolism</topic><topic>Natural killer cells</topic><topic>Neoplastic Syndromes, Hereditary - genetics</topic><topic>Neoplastic Syndromes, Hereditary - immunology</topic><topic>Neoplastic Syndromes, Hereditary - pathology</topic><topic>Oncology</topic><topic>Receptors, TNF-Related Apoptosis-Inducing Ligand - genetics</topic><topic>Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Lin</creatorcontrib><creatorcontrib>Yi, Jiahong</creatorcontrib><creatorcontrib>He, Wenzhuo</creatorcontrib><creatorcontrib>Kong, Pengfei</creatorcontrib><creatorcontrib>Xie, Qiankun</creatorcontrib><creatorcontrib>Jin, Yanan</creatorcontrib><creatorcontrib>Xiong, Zhenchong</creatorcontrib><creatorcontrib>Xia, Liangping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Lin</au><au>Yi, Jiahong</au><au>He, Wenzhuo</au><au>Kong, Pengfei</au><au>Xie, Qiankun</au><au>Jin, Yanan</au><au>Xiong, Zhenchong</au><au>Xia, Liangping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2024-07</date><risdate>2024</risdate><volume>131</volume><issue>2</issue><spage>334</spage><epage>346</epage><pages>334-346</pages><issn>0007-0920</issn><issn>1532-1827</issn><eissn>1532-1827</eissn><abstract>Background Identifying the target of natural killer (NK) cells in colorectal cancer (CRC) is critical for optimising the clinical use of NK cell-mediated immunotherapy. Mismatch repair deficiency (dMMR) is associated with high immune cell infiltration and MHC Class I defects. Whether dMMR CRC responses to NK cell therapy remains unclear. Methods MLH1, DR4, and DR5 knockout cell lines were established using CRISPR-Cas9 system. NK92-MI or NK cell isolated from BABL/C mice were used as effector cells against tumour cells. Inflammatory cytokines secretion by CRC cells was assessed via cytokine analysis. NK-cell-deficient/proficient animal models were used to validate the NK cell sensitivity. Results We observed that dMMR CRC cells were more sensitive to NK cell-mediated cytotoxicity than were mismatch-repair-proficient (pMMR) CRC cells. In dMMR CRC, Death receptor (DR)4/5 was upregulated and mediated sensitivity to NK cell-mediated cytotoxicity. DR4/5-mediated secretion of interleukin -12 sustained NK cell viability in dMMR CRC. NK cell depletion induced dMMR CRC tumour growth, and NK cell transfer inhibited lung metastasis of dMMR CRC with DR4/5 expression in vivo. TP53 upregulated DR4/DR5 expression in dMMR CRC. Conclusions dMMR associated with increased sensitivity to NK cell-mediated cytotoxicity in CRC. DR4/DR5 sensitise dMMR CRC to NK cell-mediated cytotoxicity.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>38796599</pmid><doi>10.1038/s41416-024-02673-z</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-4544-8071</orcidid><orcidid>https://orcid.org/0000-0001-7532-4913</orcidid><orcidid>https://orcid.org/0000-0002-1129-5663</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 2024-07, Vol.131 (2), p.334-346
issn 0007-0920
1532-1827
1532-1827
language eng
recordid cdi_pubmed_primary_38796599
source MEDLINE; Springer Nature - Complete Springer Journals
subjects 692/499
692/53/2422
Animal models
Animals
Biomedical and Life Sciences
Biomedicine
Brain Neoplasms
Cancer Research
Cell culture
Cell death
Cell Line, Tumor
Cell therapy
Cell viability
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - genetics
Colorectal Neoplasms - immunology
Colorectal Neoplasms - pathology
CRISPR
Cytotoxicity
Cytotoxicity, Immunologic
Death receptors
DNA Mismatch Repair
Drug Resistance
Effector cells
Epidemiology
Humans
Immunotherapy
Killer Cells, Natural - immunology
Killer Cells, Natural - metabolism
Major histocompatibility complex
Metastases
Mice
Mice, Inbred BALB C
Mismatch repair
MLH1 protein
Molecular Medicine
MutL Protein Homolog 1 - deficiency
MutL Protein Homolog 1 - genetics
MutL Protein Homolog 1 - metabolism
Natural killer cells
Neoplastic Syndromes, Hereditary - genetics
Neoplastic Syndromes, Hereditary - immunology
Neoplastic Syndromes, Hereditary - pathology
Oncology
Receptors, TNF-Related Apoptosis-Inducing Ligand - genetics
Receptors, TNF-Related Apoptosis-Inducing Ligand - metabolism
Tumors
title Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A08%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Death%20receptors%204/5%20mediate%20tumour%20sensitivity%20to%20natural%20killer%20cell-mediated%20cytotoxicity%20in%20mismatch%20repair%20deficient%20colorectal%20cancer&rft.jtitle=British%20journal%20of%20cancer&rft.au=Yang,%20Lin&rft.date=2024-07&rft.volume=131&rft.issue=2&rft.spage=334&rft.epage=346&rft.pages=334-346&rft.issn=0007-0920&rft.eissn=1532-1827&rft_id=info:doi/10.1038/s41416-024-02673-z&rft_dat=%3Cproquest_cross%3E3060747618%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3083308662&rft_id=info:pmid/38796599&rfr_iscdi=true